This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXNPEB9M0BY_M.jpg
Orbimed Advisors’s holding in Adicet Bio, Inc. increased to about 397 thousand shares with the purchase.
Orbimed Advisors first bought Adicet Bio, Inc. stock in the third quarter of 2020.
Other investors who also added to their Adicet Bio, Inc. shares include Citigroup (NYSE:C).
